Literature DB >> 20085788

Alteration of resting brain function by genetic variation in angiotensin converting enzyme in amnestic-type mild cognitive impairment of Chinese Han.

Zhengsheng Zhang1, Linglong Deng, Feng Bai, Yongmei Shi, Hui Yu, Yonggui Yuan, Kun Wang, Tianzi Jiang, Jianping Jia, Zhijun Zhang.   

Abstract

Using a cross-sectional case-control study of amnestic-mild cognitive impairment (aMCI), we characterised the relationships among cognitive function, serum levels of angiotensin converting enzyme (ACE), brain activity, and ACE insertion or deletion (I/D) polymorphism. Forty-eight patients with aMCI and 36 well-matched normal controls were assessed by a comprehensive battery of standardized neuropsychological tests. In addition, regional homogeneity (ReHo) approaches were used to analyze blood oxygen level-dependent functional magnetic resonance imaging data on the resting state in all subjects, and genotyping of the serum ACE was measured in aMCI patients. The D carriers with aMCI patients were found to have markedly higher serum ACE levels than I homozygote carriers. Importantly, compared with the carried I homozygote group of patients with aMCI, the D carriers of aMCI patients were significantly impaired in the AVLT-delayed recall and had decreased ReHo over the bilateral precuneus, left middle occipital gyrus, right inferior parietal lobe, and right angular gyrus, whilst increased ReHo was found mainly in the left medial frontal gyrus, right paracentral lobe, and right anterior cingulate cortex. The findings indicated that ACE genotype was associated with episodic memory, serum levels of ACE, and resting-state brain activity in aMCI patients, and the findings of cognitive function and brain activity further suggests that the ACE D allele may have a specific role in semantic memory dysfunction and brain activity in aMCI. Published by Elsevier B.V.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20085788     DOI: 10.1016/j.bbr.2010.01.008

Source DB:  PubMed          Journal:  Behav Brain Res        ISSN: 0166-4328            Impact factor:   3.332


  7 in total

1.  Neuroimaging measures as endophenotypes in Alzheimer's disease.

Authors:  Meredith N Braskie; John M Ringman; Paul M Thompson
Journal:  Int J Alzheimers Dis       Date:  2011-03-31

2.  Altered causal connectivity of resting state brain networks in amnesic MCI.

Authors:  Peipeng Liang; Zhihao Li; Gopikrishna Deshpande; Zhiqun Wang; Xiaoping Hu; Kuncheng Li
Journal:  PLoS One       Date:  2014-03-10       Impact factor: 3.240

3.  Association of Increased Serum ACE Activity with Logical Memory Ability in Type 2 Diabetic Patients with Mild Cognitive Impairment.

Authors:  Sai Tian; Jing Han; Rong Huang; Wenqing Xia; Jie Sun; Rongrong Cai; Xue Dong; Yanjue Shen; Shaohua Wang
Journal:  Front Behav Neurosci       Date:  2016-12-23       Impact factor: 3.558

4.  Mediation of episodic memory performance by the executive function network in patients with amnestic mild cognitive impairment: a resting-state functional MRI study.

Authors:  Baoyu Yuan; Jiu Chen; Liang Gong; Hao Shu; Wenxiang Liao; Zan Wang; Duan Liu; Chunming Xie; Zhijun Zhang
Journal:  Oncotarget       Date:  2016-10-04

5.  An Activation Likelihood Estimation Meta-Analysis of Specific Functional Alterations in Dorsal Attention Network in Mild Cognitive Impairment.

Authors:  Huimin Wu; Yu Song; Shanshan Chen; Honglin Ge; Zheng Yan; Wenzhang Qi; Qianqian Yuan; Xuhong Liang; Xingjian Lin; Jiu Chen
Journal:  Front Neurosci       Date:  2022-04-26       Impact factor: 5.152

6.  Resting-state abnormalities in amnestic mild cognitive impairment: a meta-analysis.

Authors:  W K W Lau; M-K Leung; T M C Lee; A C K Law
Journal:  Transl Psychiatry       Date:  2016-04-26       Impact factor: 6.222

7.  Alterations of brain local functional connectivity in amnestic mild cognitive impairment.

Authors:  Dan Zhen; Wei Xia; Zhong Quan Yi; Pan Wen Zhao; Jian Guo Zhong; Hai Cun Shi; Hua Liang Li; Zhen Yu Dai; Ping Lei Pan
Journal:  Transl Neurodegener       Date:  2018-11-07       Impact factor: 8.014

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.